These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11445882)

  • 21. Biotechnology--a challenge to the patent system.
    Farnley S; Morey-Nase P; Sternfeld D
    Curr Opin Biotechnol; 2004 Jun; 15(3):254-7. PubMed ID: 15193336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulating morality through patent law. Critique of the EC Directive.
    Beyleveld D
    Rev Derecho Genoma Hum; 2000; (12):141-71. PubMed ID: 11147206
    [No Abstract]   [Full Text] [Related]  

  • 23. The commercialization of biotechnology: important aspects of technology licensing.
    Irvine S
    Aust J Biotechnol; 1991 Apr; 5(2):105-8. PubMed ID: 1367321
    [No Abstract]   [Full Text] [Related]  

  • 24. Patent convention 'needs new protocol on moral issues'.
    Nature; 1995 Apr; 374(6524):665. PubMed ID: 7715712
    [No Abstract]   [Full Text] [Related]  

  • 25. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
    Schrell A; Bauser H; Brunner H
    Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical aspects of biotechnology applications.
    Siegler M
    Forum (Genova); 1999; 9(3 Suppl 3):106-12. PubMed ID: 10607855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New genetics, new ethics? Globalisation and its discontents.
    Glasner P; Rothman H
    Health Risk Soc; 2001 Nov; 3(3):245-59. PubMed ID: 15080126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced materials: testing, QC and inspection.
    White R
    Med Device Technol; 2009 Sep; 20(5):19-21. PubMed ID: 19852177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immoral gene: does it really exist?
    Zimmer FJ; Sethmann S
    Sci Eng Ethics; 2005 Jan; 11(1):97-104. PubMed ID: 15727005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The attack of the clones: patent law and stem cell research.
    Rimmer M
    J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technology: a moral evaluation. Ethical questions on the use of technology from a macro and micro perspective.
    Lappetito J
    Health Prog; 1993; 74(1):48-9, 79. PubMed ID: 10123569
    [No Abstract]   [Full Text] [Related]  

  • 32. Explanatory limitations of cognitive-developmental approaches to morality.
    Krebs DL; Denton K
    Psychol Rev; 2006 Jul; 113(3):672-5. PubMed ID: 16802888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morality and biotechnology.
    Davis NA
    South Calif Law Rev; 1991 Nov; 65(1):355-71. PubMed ID: 11645839
    [No Abstract]   [Full Text] [Related]  

  • 34. Displaced agendas: current regulatory strategies for germline gene therapy.
    Marden E; Nelkin D
    McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Religious voices in biotechnology: the case of gene patenting.
    Hanson MJ
    Hastings Cent Rep; 1997; 27(6):suppl 1-21. PubMed ID: 9474493
    [No Abstract]   [Full Text] [Related]  

  • 36. Patenting biotechnology: ethical and philosophical issues.
    Fielder JH
    IEEE Eng Med Biol Mag; 1997; 16(6):118-20. PubMed ID: 9399094
    [No Abstract]   [Full Text] [Related]  

  • 37. Euroscreen 2: towards community policy on insurance, commercialization and public awareness.
    Chadwick R; ten Have H; Hoedemaekers R; Husted J; Levitt M; McGleenan T; Shickle D; Wiesing U
    J Med Philos; 2001 Jun; 26(3):263-72. PubMed ID: 11445881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 39. Measuring biotechnology employees' ethical attitudes towards a controversial transgenic cattle project: the ethical valance matrix.
    Small BH; Fisher MW
    J Agric Environ Ethics; 2005; 18(5):495-508. PubMed ID: 16552906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hope fear and genetics: judicial responses to biotechnology.
    Gold ER
    Judicature; 1999; 83(3):132-8. PubMed ID: 12737164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.